Machine learning reveals why cancer trials fall short in real-world patients

TrialTranslator uses machine learning to assess cancer RCT generalizability, revealing survival gaps for high-risk patients and enhancing research accuracy.

Why doesn’t the U.S. have more Black midwives?

In the wake of growing alarm over the disproportionately high rates of maternal mortality in the U.S., maternal health experts have been pushing for changes

September 18, 2023

Telix’s prostate cancer imaging kit set for FDA review – Pharmaceutical Technology

Telix already has an FDA-approved imaging agent, a gallium-68 gozetotide injection marketed under the brand name Illuccix. Image credit: Shutterstock / Ezume Images. A day

July 24, 2024

Two years since Dobbs, reproductive freedom must be protected from assault

It’s been two years since America’s highest court removed a constitutional right — for the first time in history — that Americans have relied on

June 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.